Where Life-Saving Meets Lifestyle.

SOLUtion Medical is a specialty pharmaceutical company with a fully integrated supply chain for reconstitution products. Our proprietary delivery device portfolio affords patients, caregivers, and clinicians device options to fit within their lifestyles at home and in multiple healthcare settings.

Our Products

Pre-filled Syringes & Auto-injectors for Better Drug Delivery

SOLUtion was initially founded to solve the challenge of adrenal crisis, where the current standard of care simply doesn’t work for real-world life-threatening situations. Our first solutions, the Valve Technology System (VTS) Pre-filled Syringe & the TwistJECT™, are intuitive treatments for adrenal crisis that compress a 14-step process into one simple and easy-to-use solution.

28K

The average cost per hospitalization visit for those facing adrenal crisis is $28K

3X

Those facing adrenal crisis are currently three times more likely to be admitted to the hospital due to lack of effective self-injection

2X

Those admitted to the hospital due to adrenal crisis who don’t receive prompt treatment are currently two times more likely to require treatment in the ICU

SO What?

From Pre-filled Syringe to Auto-injection.

SOLUtion has created the Valve Technology System (VTS) for a dual chamber (powder and diluent) pre-filled syringe. This advanced technology simplifies powder and diluent filling across our portfolio, and we expect to leverage our VTS in both manual and automated versions across all of the indications supported by our pipeline.  Most importantly, this latest development affords patients, caregivers, and clinicians device options to fit within their workflows – and lifestyles – in multiple healthcare environments and in the home.

SO What?

Lifestyle-Driven, not Lifestyle-Defining.

When it comes to adrenal crisis, the current standard of care is not only unacceptable, but the burden of treatment can often dictate a patient's lifestyle, keeping them from living life to the fullest extent. However, adrenal crisis – and the resulting cost – is just the tip of the iceberg. Today, there are numerous indications where existing treatment options can be anywhere from inconvenient to downright burdensome.

We’re setting out to change that by building a platform to develop and administer treatments that work for real patients in the real world.

Our Vision

A Platform to Build Better Treatments.

What began as a quest to build a better solution for people like Julia has evolved into an incredible opportunity to revolutionize how drugs are developed and delivered. Our unique approach to drug and device development is empowering us to bring new treatments to patients who have had to adapt their lifestyles to fit their treatments – until now.

Our team is currently working on applying everything we learned to develop the TwistJECT™ into potential solutions for mental health and fertility, among many other indications with complex and burdensome treatments.


Julia Anthony, Founder & CSO launched SOLUtion not because she wanted to, but because she had to.

Adrenal Crisis is still deadly in the 21st century.

Adrenal crisis is a life-threatening medical emergency, associated with a high mortality unless it is appropriately recognized and early treatment is rendered. Despite it being a treatable condition for almost 70 years, failure of adequate preventive measures or delayed treatment has often led to unnecessary deaths.

Our Network of Collaborators and Advisors

Collaboration by Design. Designed by Collaboration.

We believe that the only way to design and develop better treatments for patients is to let them inform the design process right from the very beginning. We’re grateful to our robust network of collaborators who have helped bring the TwistJECT™ to life throughout every step of the process, and are now foundational to the SOLUtion journey.

CHOP • JLABS • PITUITARY FOUNDATION (UK) • PITUITARY IRELAND


The Pre-filled Syringe & TwistJECT™ are major milestones for drug reconstitution, but just the first step in our journey towards building lifestyle-driven treatments for all.

Meet the Team

  • Todd Wallach

    CEO & Board Member
    MBA, MSE, MBioTech

    LinkedIn

  • Julia Anthony

    Founder, CSO, & Board Member
    MSID

    LinkedIn

  • David Palling

    VP CMC & Supply Chain
    PhD

    LinkedIn

  • Mikael Avery

    VP Design & Innovation
    MArch, MS

    LinkedIn

  • Simon Rogers

    VP Brand Strategy & Marketing
    BA

    LinkedIn

Connect With Us

Help Us To Help Those Awaiting Better Treatments.

For Investors


Current investors looking for the latest on our progress, or potential investors looking to get involved, please contact us here

For Partners


For biopharma and medical device companies looking to build new or proprietary solutions for your products, please contact us here

For Patients


For patients looking to help inform the development of better solutions for adrenal crisis and beyond, please contact us here

General


For all other inquiries (including press and media inquiries), please contact us here